Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VP35 is a multifunctional protein encoded by filoviruses, most notably the Ebola virus (EBOV). It plays critical roles in viral replication, immune evasion, and pathogenesis. VP35 is not an enzyme but acts as a cofactor and structural component within the viral machinery. It serves as a nonenzymatic component of the viral RNA synthesis machinery, suppresses host innate immune responses by inhibiting RIG-I signaling pathways, interferes with dendritic cell maturation, and suppresses RNA interference (RNAi).
Disruption of dsRNA binding, inhibition of RIG-I signaling, interference with NP interaction, inhibition of PKR autophosphorylation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral Protein 35 (VP35).